Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Clarity Pharmaceuticals Ltd. ( (AU:CU6) ).
Clarity Pharmaceuticals Ltd. has announced a significant change in its substantial holders, with State Street Corporation and its subsidiaries, including State Street Bank and Trust Company, acquiring a notable interest in the company. This development indicates a strategic move by State Street to increase its influence in Clarity Pharmaceuticals, potentially impacting the company’s governance and future strategic decisions.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$6.10 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 2,620,883
Technical Sentiment Signal: Sell
Current Market Cap: A$780.9M
See more insights into CU6 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue